Related by context. All words. (Click for frequent words.) 72 Onrigin 68 Cloretazine 68 refractory chronic lymphocytic 67 azacitidine 67 Zemplar Capsules 67 oral ridaforolimus 66 mifamurtide 66 TYGACIL 66 paclitaxel poliglumex 66 CIMZIA ™ 66 MEPACT 65 REVLIMID lenalidomide 65 Fibrillex TM 65 Torisel 65 low dose cytarabine 65 Exforge HCT 65 Fludara 65 TAXOTERE R 65 Elitek 65 oral rivaroxaban 65 MAGE A3 ASCI 65 lenalidomide Revlimid R 65 ALGRX 65 oxaliplatin Eloxatin 65 IV acetaminophen 65 remission induction 65 melphalan prednisone 65 Cloretazine R VNP#M 65 CIMZIA TM 65 OPAXIO 64 Taxotere ® 64 SILENOR TM 64 cisplatin gemcitabine 64 YERVOY 64 biologic DMARD 64 MoxDuo IR 64 refractory Hodgkin lymphoma 64 SPRYCEL ® 64 ADVANCE PD 64 dextromethorphan quinidine 64 oxymorphone ER 64 Dyloject TM 64 TORISEL 64 alvimopan 64 Zenvia ™ 64 vinorelbine 64 Dacogen injection 64 Benazepril 64 Anthim 64 Gemzar ® 64 Increlex ® 64 forodesine 64 doripenem 64 laromustine 64 Elagolix 64 riociguat 63 CANCIDAS 63 PREOS R 63 palifosfamide 63 AeroLEF TM 63 EndoTAG TM -1 63 ORENCIA ® 63 Triapine R 63 Pemetrexed 63 CIMZIA TM certolizumab pegol 63 EXPAREL ™ 63 APTIVUS 63 oral diclofenac 63 Ranolazine 63 Amrubicin 63 evaluating satraplatin 63 efalizumab 63 PREZISTA r 63 interferon gamma 1b 63 Allovectin 7 ® 63 DexaSite 63 telaprevir dosed 63 CoFactor 63 tipranavir 63 LibiGel ® 63 Tiuxetan 63 posaconazole 63 TREDAPTIVE 63 pegylated interferon alfa 2b 63 sorafenib tablets 63 YONDELIS 63 lanthanum carbonate 63 EFAPROXYN 63 Alvesco R 63 docetaxel Taxotere ® 63 active comparator 63 mapatumumab 63 Azedra 63 UPLYSO 63 EOquin 63 Octreolin 63 Glufosfamide 63 PEGINTRON TM 63 ceftazidime 63 Urocidin TM 63 RAPTIVA 63 Decitabine 63 hoFH 62 ARIXTRA R 62 trabectedin 62 MYDICAR ® 62 INCB# [001] 62 Pegasys peginterferon alfa 2a 62 Proxinium TM 62 PHX# 62 relapsed refractory multiple myeloma 62 relapsed MM 62 divalproex sodium 62 Alocrest 62 custirsen 62 ARCOXIA 62 Tumor Response 62 DAVANAT 62 galiximab 62 Phase Ib study 62 randomized multicenter Phase III 62 Tarceva TM 62 ARIXTRA 62 Dacogen decitabine 62 ORENCIA R 62 Junovan 62 Neurodex 62 SPRIX ® 62 herpetic keratitis 62 Clolar ® 62 Diabetic Macular Edema 62 Navelbine ® 62 bevacizumab Avastin ® 62 MGd 62 NOXAFIL 62 carboplatin paclitaxel 62 sargramostim 62 Raptiva r 62 NeuroSTAT ® 62 BeneFIX 62 CHAMPION PCI 62 Ozarelix 62 TELCYTA 62 Dabigatran etexilate 62 MERLIN TIMI 62 Civacir 62 HuLuc# 62 RhuDex ® 62 darunavir r 62 Anturol TM 62 Xanafide 62 VELCADE melphalan 62 pancreatic insufficiency 62 CLARITY study 62 ATPace TM 62 lintuzumab 62 PRISTIQ 62 Privigen 62 QNEXA 62 rFVIIa 62 TYKERB 62 CALGB # [002] 62 MEK Inhibitor 62 Randomized Evaluation 62 insulin detemir 62 ularitide 62 Pennsaid R 62 bazedoxifene 62 inhaled AAT 62 Gliadel Wafer 62 REVLIMID R 62 Cimzia TM 62 ONTAK 62 MYCAMINE 62 rALLy trial 62 ELACYT 62 comparator arm 62 FROVA 61 Increlex R 61 MabCampath 61 dose escalation phase 61 INC# 61 TYZEKA 61 Tekturna HCT 61 L MTP PE 61 APTIVUS r 61 JANUVIA 61 acyclovir Lauriad ® 61 dosing cohorts 61 RAPAFLO 61 Keppra XR 61 bendamustine 61 IONSYS TM 61 ARCALYST ® 61 CERVARIX 61 Prospective Randomized 61 TEMODAL 61 tocilizumab 61 fluoropyrimidine 61 elotuzumab 61 OncoVEX GM CSF 61 Dalbavancin 61 xanthine oxidase inhibitor 61 zonisamide SR 61 NDA Submission 61 CCX# 61 Velcade bortezomib 61 CINQUIL 61 RSD# oral 61 INTERCEPT platelets 61 HCV SPRINT 61 Mylotarg 61 subcutaneously administered 61 invasive candidiasis 61 pharmacokinetic PK study 61 Q#IR 61 Xelox 61 Myocet 61 Bezielle 61 sorafenib Nexavar 61 hylan GF 61 ATACAND 61 MOZOBIL 61 octreotide acetate 61 sunitinib malate 61 CEQ# 61 oral beclomethasone dipropionate 61 randomized Phase 2b 61 ADAGIO study 61 LEUKINE 61 RHUCIN 61 PROMACTA 61 Targretin capsules 61 favorable pharmacokinetic profile 61 telbivudine 61 ONGLYZA 61 Traficet EN 61 Bazedoxifene 61 GSK# [001] 61 nab paclitaxel 61 Keppra R 61 glatiramer acetate 61 MYLOTARG 61 thalidomide Thalomid 61 TMC# C# 61 peginterferon alfa 2b 61 Phase #b/#a clinical 61 Voreloxin 61 Chemophase 61 alemtuzumab MS 61 MYDICAR 61 basal bolus regimen 61 generation purine nucleoside 61 EURIDIS 61 THALOMID 61 Phase IIIb clinical 61 ACTEMRA TM 61 sublingual tablets 61 relapsed multiple myeloma 61 diarrhea predominant irritable 61 TRISENOX ® 61 Investigational Treatment 61 Aplidin R 61 miconazole Lauriad ® 61 BrachySil 61 Vidaza azacitidine 61 vidofludimus 61 maximally tolerated dose 61 ISTODAX 61 refractory multiple myeloma 61 Phase IIB 61 TLK# 61 reslizumab 61 Irinotecan 61 Allovectin 7 61 Cellegesic 61 Dasatinib 61 NATRECOR ® 61 canakinumab 61 XYOTAX TM 61 NATRECOR R 61 KRN# 61 Restanza 61 LHRH antagonists 61 PrevOnco ™ 61 Moxifloxacin 61 Glatiramer Acetate 61 somatostatin analog 60 pomalidomide 60 Genasense R oblimersen 60 AIR CF1 60 Cleviprex TM clevidipine 60 PNP inhibitor 60 palonosetron 60 PrevOnco 60 Cimzia ® certolizumab pegol 60 docetaxel Taxotere R 60 FIRAZYR 60 QuadraSphere 60 GAMMAGARD 60 PRIALT 60 pharmacologically active isomer 60 pegylated liposomal doxorubicin 60 IV Busulfex 60 R# #mg BID 60 LUMINATE 60 pegylated alpha interferon 60 FIRMAGON 60 placebo controlled Phase III 60 AGGRASTAT R 60 Phase 1a clinical 60 oral talactoferrin 60 balsalazide tablet 60 sitaxsentan 60 trastuzumab Herceptin R 60 BYETTA ® 60 thymalfasin 60 decitabine 60 ThermoDox ® 60 Hyphanox 60 tacrolimus ointment 60 non metastatic osteosarcoma 60 abatacept 60 CORDAPTIVE 60 RE LY ® 60 antiarrhythmic drug 60 CAELYX 60 hydrochloride capsules 60 Certican 60 OvaRex ® MAb 60 AzaSite Plus 60 Soliris eculizumab 60 Raptiva ® 60 Engerix B 60 protease inhibitor PI 60 IXEMPRA 60 XYNTHA 60 Panzem R 60 amrubicin 60 evaluating tivozanib 60 KAPIDEX 60 Tekamlo 60 celgosivir 60 AZILECT ® 60 casopitant 60 SinuNase TM 60 IRESSA 60 Genasense ® oblimersen 60 Xyrem ® 60 Omacetaxine 60 TREANDA 60 cIAI 60 Specifid 60 LibiGel Phase III 60 ACOMPLIA R 60 standard chemotherapy regimen 60 Virulizin R 60 TELINTRA 60 octreotide implant 60 ARIKACE 60 ONCASPAR 60 candesartan cilexetil 60 OHR/AVR# 60 ONGLYZA ™ 60 ISENTRESS 60 Anturol 60 Biologic License Application BLA 60 Thalomid ® 60 relapsing multiple sclerosis 60 Altastaph 60 NXL# 60 Zorbtive TM 60 BRIM2 60 Tamibarotene 60 systemic immunosuppressive drugs 60 Degarelix 60 metastatic hormone refractory 60 everolimus eluting stents 60 PROSTVAC VF 60 PEGylated interferon 60 Aptivus ® 60 Uvidem 60 Tracleer R 60 bicifadine 60 teriflunomide 60 HuMax CD4 60 Icatibant 60 nadolol 60 Vandetanib 60 intravesical infusion therapy 60 acyclovir Lauriad R 60 SPIRIVA HandiHaler 60 Combo Stent 60 PSMA ADC 60 Copegus ribavirin 60 SIMCOR 60 Arixtra ® 60 proprietary transdermal patch 60 Cimzia R 60 Androxal TM 60 Teriparatide 60 APTIVUS R 60 Gamunex C 60 teduglutide 60 surrogate endpoint 60 AGGRASTAT ® 60 TORISEL TM 60 Ophena TM 60 PREZISTA ritonavir 60 methylnaltrexone bromide 60 EOquin TM 60 dorzolamide 60 MEND CABG II 60 rhITF 60 NSABP B 60 fosbretabulin 60 PhosLo 60 clevidipine 60 bevacizumab Avastin 60 Leukine ® 60 methylnaltrexone 60 candidemia 60 Multaq R 60 investigational monoclonal antibody 60 Onbrez Breezhaler 60 See CLINICAL PHARMACOLOGY 60 PREZISTA 60 constipation OIC 60 BCIRG 60 Noxafil 60 DU #b 60 LIALDA 60 HuMax EGFr 60 5 HT3 antagonist 60 microplasmin Phase III 60 GnRH antagonist 60 thetreatment 60 ISTODAX ® 60 pharmacokinetic PK 60 VPRIV 60 Exelixis XL# 60 azilsartan medoxomil 60 Virulizin ® 60 HYLENEX recombinant 60 Mycophenolate Mofetil 60 Val HeFT 60 FOSRENOL ® 60 containing granisetron 60 pharmacokinetic equivalence 60 novel emulsion formulation 60 metastatic castration resistant 60 aflibercept 59 velafermin 59 Bendamustine 59 rilonacept 59 Panzem R NCD 59 pitavastatin 59 MAA submission 59 OraTest R 59 Fondaparinux 59 vinca alkaloid 59 recurrent glioblastoma multiforme 59 Pegloticase 59 TMC# [002] 59 recurrent glioma 59 tesmilifene 59 R roscovitine 59 Halozyme Ultrafast Insulin 59 noninfectious uveitis 59 bortezomib Velcade 59 Phase Ib II 59 5 Fluorouracil 59 icatibant 59 neratinib 59 Removab 59 phase IIb III 59 BUPHENYL 59 CREON R 59 GnRH agonist 59 SUTENT ® 59 sapacitabine 59 R#/MEM # 59 chemoradiation therapy 59 Rilonacept 59 Meets Primary Endpoint 59 APF# 59 tolevamer 59 ezogabine 59 oral iron chelator 59 oral FTY# 59 Complete Response 59 LHRH agonist 59 phase IIb clinical 59 desvenlafaxine succinate 59 ancrod 59 Darunavir 59 SNT MC# 59 Dapagliflozin 59 invasive aspergillosis 59 viral kinetics 59 DEB# 59 AEG# 59 Doxil ® 59 Rasilez Tekturna 59 cinacalcet HCl 59 SILENOR ™ 59 Pirfenidone 59 MIVI III 59 NEBIDO 59 Inhalation Solution 59 EDEMA3 59 NAVISTAR R 59 treatment naive genotype 59 Acute Ischemic Stroke 59 Non inferiority 59 INTEGRILIN ® 59 anidulafungin 59 Lysteda 59 somatostatin analogue 59 Plenaxis TM 59 postmenopausal osteoporotic women 59 FOLOTYN ® 59 ZEGERID Capsules 59 Trobalt 59 Combunox 59 BCX# 59 brivaracetam 59 Tipranavir 59 SILENOR 59 OMS# 59 PRT# 59 tanespimycin 59 antithrombotics 59 SUPPRELIN R LA 59 angiographic outcomes 59 GATTEX TM 59 RIGScan CR 59 Gonal f 59 vorinostat 59 histamine dihydrochloride 59 Keppra ® 59 opioid induced bowel dysfunction 59 BLA filing 59 PROVENGE sipuleucel T 59 hereditary deficiency 59 LymphoStat B belimumab 59 EDEMA3 trial 59 Medoxomil 59 mesalamine granules 59 cSSSI 59 trastuzumab Herceptin ® 59 Filgrastim 59 ospemifene 59 AVOREN 59 dextofisopam 59 Levoleucovorin 59 Interferon alfa 59 Ixempra 59 BCR ABL inhibitor 59 Nexavar ® 59 PEG SN# 59 active moiety 59 NVA# 59 Pivotal Phase 59 rFSH 59 omecamtiv mecarbil 59 mg kg BID 59 PDX pralatrexate 59 Phenoptin 59 Vivaglobin 59 Biological License Application 59 Brinavess 59 oral deforolimus 59 phase IIIb 59 Mycophenolate mofetil 59 CLORETAZINE TM VNP#M 59 VAPRISOL 59 refractory acute myeloid 59 PREOS 59 GVAX Pancreas Vaccine 59 pain palliation 59 Amplimexon 59 Pentacel vaccine 59 Entereg TM 59 Ventavis 59 Neovasc Reducer 59 pediatric acute lymphoblastic 59 Ketotransdel TM 59 external beam radiotherapy 59 RenalGuard System TM 59 vapreotide acetate 59 Jevtana 59 oxypurinol 59 pegfilgrastim 59 ADVEXIN therapy 59 PEG INTRON R 59 piperacillin tazobactam 59 Golimumab 59 Mepact 59 Fibrin Pad 59 Zenvia Phase III 59 OMNARIS HFA 59 CRMD# 59 Perforomist ™ Inhalation Solution 59 FASLODEX 59 confirmatory clinical 59 Carvedilol 59 AZILECT R 59 eprodisate Fibrillex TM 59 IPLEX 59 R lenalidomide 59 REMICADE ® 59 Cloretazine ® 59 Valsartan 59 ZOLINZA 59 fenofibric acid 59 Phase IIa trials 59 pharmacodynamic parameters 59 coronary stent merged 59 Prodarsan ® 59 ARCALYST ® rilonacept 59 PIX# [002] 59 Initiate Clinical Trial 59 Proellex TM 59 Spiriva Handihaler 59 Actimmune ® 59 Kepivance 59 efavirenz EFV 59 KNS # 59 Vaprisol 59 mGluR5 NAM 59 Calcium Acetate 59 Ketotransdel 59 DASISION 59 Retisert 59 Durezol TM 59 MoxDuo 59 BARACLUDE R 59 BrachySil TM 59 Natroba 59 CABP 59 Demonstrates Sustained 59 RoACTEMRA 59 Camptosar ® 59 IFN α 59 vinorelbine tartrate 59 romidepsin 59 Mycamine 59 inhaled treprostinil 59 Inhaled AAT 59 gemcitabine Gemzar ® 59 raxibacumab 59 Telavancin 59 STEDESA 59 HGS ETR2 59 Vernakalant 59 Frova ® 59 octreotide 59 Multiple Ascending Dose 59 VNP#M 59 Epoetin alfa 59 fluvastatin 59 GATTEX ™ 59 Ibritumomab Tiuxetan 59 metastatic neuroendocrine tumors 59 Interferon beta 59 oral renin inhibitor 59 paliperidone palmitate 58 catheter occlusion 58 EFFEXOR XR 58 Fulvestrant 58 esophageal candidiasis 58 dacetuzumab 58 DAPT 58 tezampanel 58 pertuzumab 58 Clevudine 58 CMV disease 58 Vancocin R 58 VIBATIV 58 hepatitis B immunoglobulin 58 Intravenous CP 58 Androxal ® 58 IoGen 58 Genasense 58 alvespimycin 58 Rapaflo 58 inhibitor RG# 58 LATISSE ™ 58 ELADUR 58 BR.# 58 phase Ib 58 eltrombopag 58 cUTI 58 Epirubicin 58 torezolid phosphate 58 phase IIb trial 58 AZOR 58 BENLYSTA ® 58 ablative therapy 58 Randomized Double blind 58 Evoltra 58 desvenlafaxine 58 STRIDE PD 58 selective androgen receptor modulator 58 Phase #b/#a 58 Hepatocellular Carcinoma HCC 58 BENICAR 58 OncoGel 58 calcineurin inhibitor 58 oral anticoagulant 58 eosinophilic asthma 58 antiplatelet agent 58 Aflibercept 58 CIP TRAMADOL ER 58 complement inhibitor eculizumab 58 mg BID dose 58 placebo controlled clinical 58 Angiox R 58 risedronate sodium tablets 58 Vfend 58 REMICADE infliximab 58 Bayer Onyx 58 Zemplar 58 pemetrexed Alimta 58 hemostatic efficacy 58 RSD# 58 orBec R 58 #:# randomization 58 Ceflatonin ® 58 CIP ISOTRETINOIN 58 schizophrenia CIAS 58 pharmacodynamic properties 58 Ramelteon 58 sevelamer carbonate 58 Sipuleucel T 58 elagolix 58 Solesta 58 AEGR 58 ZYVOX 58 Sym# 58 Zerenex 58 delivers fluocinolone acetonide FA 58 mometasone furoate 58 Hycamtin 58 Phase III randomized controlled 58 atypical antipsychotic medication 58 Nipent R 58 IMA# 58 PROPEL trial 58 mRCC 58 Prodarsan R 58 Liprotamase 58 Thrombin 58 Oral Fingolimod 58 multicentre randomized 58 DepoDur 58 ILUVIEN 58 elective PCI 58 ACZ# 58 clinical endpoints 58 SCHWARZ PHARMA 58 Renvela ® 58 lucinactant 58 DDP# 58 Cefepime 58 trastuzumab DM1 T DM1 58 Melphalan 58 mycophenolate mofetil MMF 58 HSCT 58 Plenaxis R 58 primary hypercholesterolemia 58 NEUMUNE 58 GOUT 58 RSD# iv 58 trastuzumab emtansine T DM1 58 efficacy tolerability 58 Vimpat R 58 Aquavan Injection 58 oral prodrug 58 malignant ascites 58 LEP ETU 58 Study Evaluating 58 vernakalant hydrochloride 58 Advagraf 58 induced macular edema 58 Neuradiab 58 FAME Study 58 Wellbutrin XL R 58 Emezine 58 Metastatic Colorectal Cancer 58 Genz # 58 Hizentra 58 thrombolytic agent 58 lanreotide 58 Cinryze TM 58 DORIBAX 58 clinical pharmacology studies 58 Glatiramer acetate 58 Herceptin trastuzumab 58 Initiated Phase 58 lomitapide 58 refractory CLL 58 QUADRAMET R 58 PROCRIT R 58 Phase III Trial 58 EMEND 58 RezularTM 58 sodium Injection 58 thrombus aspiration 58 intravenous methylnaltrexone 58 Epratuzumab 58 thorough QT 58 LUNESTA TM 58 lumiliximab 58 Delcath PHP System 58 platelet inhibitor 58 Zelrix 58 CD# monoclonal antibody 58 CINTREDEKIN BESUDOTOX 58 blinded randomized placebo controlled 58 TRO# 58 arsenic trioxide injection 58 INTEGRILIN 58 Genzyme Synvisc 58 BLP# Liposome Vaccine 58 randomized Phase III 58 Prestara TM 58 Nexavar sorafenib 58 allogeneic stem cell 58 preclinical efficacy 58 Aryplase 58 sBLA 58 RX ACCULINK 58 miglustat 58 OvaRex R 58 PROVENGE ® 58 pharmacokinetic interactions 58 Zavesca R 58 Romiplostim 58 CAPHOSOL 58 Tindamax 58 chemotherapy induced neutropenia 58 Luteinizing Hormone Releasing Hormone 58 PEG IFN 58 PD LID 58 partial remissions 58 Resolute DES 58 Expedited Review 58 Hsp# Inhibitor 58 Xcytrin R 58 pharmacokinetic studies 58 PSVT 58 ganetespib 58 gefitinib Iressa 58 SCH # 58 BARACLUDE r 58 lenalidomide dexamethasone 58 Safinamide 58 VIVITROL ® 58 Neulasta ® 58 busulfan 58 Kuvan sapropterin dihydrochloride 58 metformin accumulation 58 Exelon Patch 58 Phase IIb Clinical Trial 58 REBETOL combination therapy 58 IV APAP 58 ALN TTR# 58 QVAR ® 58 mesylate 58 Long Term Efficacy 58 MyVax R 58 Tesmilifene 58 Hepatotoxicity 58 IMPACT IMmunotherapy 58 HGS# 58 PrandiMet TM 58 null responder HCV 58 EMBEDA ™ 58 Actemra tocilizumab 58 IFN alfa 58 Alzhemed TM 58 Quinamed 58 Prostate AdenoCarcinoma Treatment 58 Rasilez HCT 58 granisetron 58 LHRH antagonist 58 antithrombotic therapy 58 LEVADEX ™ 58 ATL/TV# 58 Betaseron ® 58 Raptiva R 58 GW# [003] 58 Arikace 58 PEG INTRON 58 Decompensated Heart Failure 58 liposomal formulation 58 hepatitis C HCV 58 ganaxolone 58 eculizumab therapy 58 nonclinical studies 58 Zarnestra 58 IL# PE#QQR 58 SABCS 58 alefacept 58 Vilazodone 58 BLA submission 58 Gabapentin GR 58 INTEGRILIN R eptifibatide Injection 58 LB# [003] 58 radiation sensitizer 58 cell lymphoma CTCL 58 Valortim ® 58 Levetiracetam 58 pioglitazone HCl 58 ATPace 58 #D#C# 58 Peginterferon alfa 2b 58 phase IIb 58 Saforis 58 Phase #/#a trial 58 Candesartan 58 Ziprasidone 58 Advanced Renal Cell 58 Phase III Clinical Trial 58 Adalimumab 58 FOLFIRINOX 58 SPIRIVA ® 58 capecitabine Xeloda 58 Angiox ® 58 losartan potassium 57 ibandronate 57 treprostinil 57 SEROQUEL XR 57 epoetin zeta 57 Paromomycin 57 Antitumor Activity 57 prospective randomized multicenter 57 Rasilamlo 57 IMiDs ® compound 57 Hypoactive Sexual Desire Disorder 57 PI3K/Akt pathway inhibitor 57 uricase 57 Serdolect ® 57 Vion Pharmaceuticals 57 LEXIVA r 57 Renal Cell Carcinoma RCC 57 ziconotide 57 Omigard 57 LymphoStat B TM 57 Phase IIb Trial 57 nasal calcitonin product 57 Interagency Registry 57 ClearPath HDR 57 CCX# B 57 R0 resection 57 Eluting Stent 57 wilate ® 57 double blinded placebo 57 Yondelis ® 57 Hectorol R 57 faropenem 57 Neulasta R 57 antiangiogenic agent 57 FavId 57 Pulmonary Arterial Hypertension 57 Cethromycin 57 JOULFERON 57 rALLy clinical trial 57 ThermoDox R 57 ferumoxytol Injection 57 PIX# trial 57 Besivance 57 ZOSTAVAX 57 ASCEND HF 57 Imprime PGG 57 ofatumumab 57 Telatinib 57 ALISTA 57 CYT# potent vascular disrupting 57 HepaGam B TM 57 Azilect ® 57 elacytarabine 57 Fludara ® 57 Entereg R 57 capsule formulation 57 Centralized Procedure 57 Zenvia 57 Campath alemtuzumab 57 Soliris TM eculizumab 57 FDA APPROVES 57 TAXUS TM 57 unstable angina pectoris 57 NeuroStar TMS Therapy 57 Randomized Phase II 57 ritonavir boosted 57 VP# [004] 57 Somatuline R Autogel R